Agios Pharmaceuticals Inc 2021 Sustainability Report
Company: Agios Pharmaceuticals Inc
Sector: Manufacturing
Country: United States
Year: 2021
Type: Sustainability Report
Pages: 43
The report presents Agios' 2021 ESG disclosures aligned with SASB and the UN SDGs. It highlights a five-year pledge not to increase PYRUKYND pricing and a U.S. copay program lowering eligible prescriptions to $0. ESG oversight includes regular updates to the Board of Directors.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.